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Objectives The objective of this work was to review the scientific articles on the use of 29 
nociceptive threshold testing (NTT) in cats, and to summarise the clinical and 30 
experimental applications in this species.  31 
 32 
Databases used Pertinent literature was searched with PubMed, Scopus, Web of 33 
Science, Universitätsbibliothek Basel (swissbib Basel Bern) and Google Scholar. The 34 
search was then refined manually based first on article titles and abstracts, and 35 
subsequently on full texts. 36 
 37 
Conclusions Of the four classical acute nociceptive models used for NTT, thermal and 38 
mechanical are most commonly used in cats. Thermal stimulation is applicable in 39 
experimental settings and has been used in pharmacodynamics studies assessing feline 40 
antinociception. Although mechanical stimulation is currently less used in cats, in the 41 
future it might play a role in the evaluation of clinical feline pain. However, the low 42 
response-reliability after stimulus repetition within a narrow time interval represents a 43 
major limitation for the clinical use of mechanical thresholds (MT) in this species.  44 
Challenges remain when thermal thresholds (TT) are us d to investigate 45 
analgesics that have the potential to affect skin temperature, such as opioids and alpha 46 
2-adrenergic agonists, and when a model of inflammatory pain is reproduced in 47 
experimental cats with the purpose of evaluating NSAIDs as analgesics.  48 
  49 
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Nociceptive threshold testing (NTT) makes use of a broad range of stimulation methods 53 
to assess and quantify nociceptive function and respon e. Most protocols described in 54 
cats have been developed for cutaneous application of mechanical and thermal 55 
stimulation. However, mechanical NTT has also been successfully applied to hollow 56 
viscera (Briggs et al. 1998).  57 
Regardless of the type of stimulation used in the experimental setting, a realistic 58 
reproduction of clinical pain is probably impossible to achieve. Although characterised 59 
by a number of different features, a common denominator of clinical pain is its 60 
complexity and the diversity of the nociceptors involved where mechanical, thermal and 61 
chemical stimuli may all contribute to the activation of afferent pathways during 62 
postoperative surgical pain. 63 
Nociception and pain are considered distinct processes. Nociception begins with 64 
the detection of injurious stimuli by a class of specialised receptors, with transmission 65 
of that information to the spinal cord and on up to the brain. This may result in a 66 
defensive, immediate reflex response (Sneddon, 2017). All reflexes, including those 67 
associated with nociception, are organised by centres at the lower hierarchy of the 68 
central nervous system; they can be elicited in decerebrated animals and are 69 
characterised by either autonomic or basic motor responses, including increased heart 70 
rate, withdrawal and muscular contractions (Woodworth & Sherrington 1904; Sneddon 71 
2017). Complex behaviours, in response to noxious stimuli, can also include 72 
conditioned motor responses, usually as a result of learning (Le Bars et al. 2001). Pain 73 
is a negative affective and psychological response and is often accompanied by more 74 
complex or prolonged behavioural alterations indicative of discomfort, such as distrust 75 
of objects associated 76 
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with painful experiences and/or modification of social behaviour. Nociception may not 77 
result in pain, because of the ability of the central nervous system to modify nociceptive 78 
signals and prevent conscious perception of noxious stimuli, and pain can occur without 79 
nociception in the presence of central sensitisation. However, pain resulting from injury 80 
cannot occur without nociception (Sneddon 2017). 81 
There is a huge body of literature on NTT in rodents, however these animals are 82 
often genetically very similar, leading to minimal variance in the detected thresholds. 83 
Cats used in research are, by comparison, much moregen tically diverse and so it is 84 
expected that there will be greater variance in any tested population. There are many 85 
reports focusing on the application of NTT to cats. Older reports were aimed at 86 
investigating particular aspects of the afferent nociceptive organisation, or at 87 
establishing patterns to relate the neurophysiological activity of the sensory system to 88 
behavioural responses indicative of nociception (Beck t al. 1974; Casey & Morrow 89 
1983). In contrast, more recent work has primarily focused on the pharmacodynamics of 90 
analgesic drugs in cats, with the purpose of identifyi g useful doses, routes of 91 
administration, onset times and duration of the effcts (Millette et al. 2008; Pypendop et 92 
al. 2009; Ambros & Duke 2013). 93 
When performing NTT testing it is important for the stimulus to be applied at a 94 
rate that will allow for conduction and interpretation of the stimulus. If the increase in 95 
stimulus strength is very rapid it might reach an excessively high level before the 96 
animal has had a chance to respond. It is also important that the approach can detect 97 
hyperalgesia as well as analgesia. In tests that use latency to the response, a very short 98 
latency will not likely allow for the detection of hyperalgesia. 99 
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The objective of this work is to review the use and the clinical and experimental 100 
applications of NTT in cats, with particular focus on acute nociceptive models, and on 101 
the literature of the past 20 years.  102 
 103 
Databases used and literature search 104 
A literature search was conducted using PubMed, Scopus, Web of Science, 105 
Universitätsbibliothek Basel (swissbib Basel Bern) a d Google Scholar. The keywords 106 
sets used for the initial screening were the following: ‘nociceptive threshold testing + 107 
cats/feline’, ‘quantitative sensory testing/QST + cats/feline’, 108 
‘mechanical/thermal/electrical thresholds + cats/feline’, ‘mechanical/thermal/electrical 109 
nociceptive model/antinociception + cats/feline’, ‘antinociceptive/analgesic 110 
effects/efficacy + cats/feline’, and ‘antinociceptive/analgesic pharmacodynamics + 111 
cats/feline’.  112 
The search was refined based first on article titles and abstracts, and subsequently 113 
on full texts of the selected scientific reports. The reference list of each retrieved 114 
scientific paper was then scrutinised to identify further pieces of literature pertaining to 115 
the topic. All the identified scientific peer-review articles written in the English 116 
language and pertaining to the topic were included in the study. Related anaesthesia and 117 
neurophysiology textbooks were also reviewed.  118 
The refined search identified 51 articles published b tween 1983 and 2019. Of 119 
these, nine were on the use of mechanical threshold (MT) (of which six were 120 
experimental and three were clinical studies), 34 experimental studies were on the use 121 
of TTs, and eight on the use of both mechanical and TTs (of which one was a clinical 122 




Mechanical stimulation 125 
Mechanical stimulation has been used in cats to elicit mostly somatic, but also visceral 126 
nociception, in both experimental and clinical settings. Visceral nociception has been 127 
experimentally induced by inflating balloon catheters inserted into the rectum (Sawyer 128 
& Rech 1987; Briggs et al. 1998). Somatic nociception is induced and assessed by 129 
applying a force to a given area of the body. Force is defined as the push or pull on an 130 
object that causes it to change velocity; pressure is a measure of force per unit area. 131 
Therefore, for the outcome values to be comparable between devices that measure 132 
different variables, the surface area of the probe must be known, and recognised as part 133 
of the applied stimulus. A nociceptive threshold is defined, depending on the device 134 
used, as either the pressure (expressed in mmHg) or the force (expressed in g or 135 
Newtons) reached when the stimulus is intense enough to elicit a behavioural, conscious 136 
response in the cat, which is subjectively determined by the operator. Ideally, the 137 
stimulating probe should be applied perpendicular to the test site in order to ensure that 138 
the measured force has been wholly applied to the area of interest. There should be 139 
minimal distensible tissue so that the mechanical stimulus is not spread over a large 140 
surface area or that the stretching tissue attenuats the force applied. Mechanical stimuli 141 
are usually applied progressively and incrementally until a cut-off value is reached; the 142 
speed of increased force is variable and, for manual algometers, is operator dependent. 143 
Both sharp-ended pins and flat-ended/blunt probes have been used in animals (Moens et 144 
al. 2003; Haussler & Erb 2006; Machin et al. 2019).  145 
It is commonly accepted that the elicited behaviours represent supraspinal 146 
responses to activation of nociceptors located in the skin, muscles and periosteum (Le 147 
Bars et al. 2001). Both myelinated Aδ fibres, with intermediate conduction speeds, and 148 
small, unmyelinated, slow-conducting C fibres are expected to be activated primarily, 149 
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but conventional noxious mechanical stimuli do not produce selective activation of 150 
these nerve types (Le Bars et al. 2001). In some subjects/patients, activation of the Aß 151 
fibres, in response to touch and pressure, may be sufficient to evoke behavioural 152 
responses that could easily be misinterpreted as sign  of nociception. This is more likely 153 
in the case of algometers that are applied intermittently than those that maintain contact 154 
with the skin where the Aß stimulation would be ongi . As a result, one disadvantage 155 
of intermittently applied mechanical stimulation is a potential lack of specificity.  156 
Several instruments have been specifically developed to perform mechanical 157 
stimulation in cats (Table 1). Slingsby and colleagues designed a finger-mounted 158 
algometer (Slingsby et al. 2001). The probe was made of a Force-Sensing Resistor 159 
(FSR), a thick polymer film, which exhibits a progressive decrease in resistance with 160 
increasing force applied to its surface. The 15 mm diameter-probe was soldered to a 161 
ribbon cable, connected to a battery powered measuring nit, calibrated with an accurate 162 
load beam and mounted on the index finger of the operator. The outcome force resulting 163 
from the application of the probe on the skin of the cat was expressed in Newtons. This 164 
device was subsequently used to evaluate the analgesic effect of post-operative 165 
meperidine in male cats undergoing castration, and i  another clinical study 166 
investigating NSAID associated analgesia in 40 femal  cats undergoing 167 
ovariohysterectomy (OVH) (Slingsby & Waterman-Pearson 2000; Slingsby et al. 2001). 168 
Changes in MTs measured at the scrotum before and after surgery differentiated 169 
between meperidine and the negative control group in male cats. In female cats, 170 
thresholds measured at the surgical wound following OVH were lower than those 171 
measured before surgery. The authors did not state how quickly the force was applied in 172 
either study and did not describe how or where the probe was applied in the OVH study 173 
(Slingsby & Waterman-Pearson 2000; Slingsby et al. 2001). 174 
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Another pressure testing device for use in cats was designed in 2007 by Dixon and 175 
colleagues (Dixon et al. 2007) and subsequently manufactured by Topcat Metrology Ltd 176 
(UK), marketed under the trade name “ProD-Plus”. The device was composed of a 5 g 177 
plastic bracelet, inside which the authors mounted a blood pressure bladder and three 178 
brass pins, each tipped with a 2.4 mm diameter ball bearing, distributed 10 mm apart in 179 
a triangular pattern to apply a perpendicular pressure to the limb. For this device, the 180 
outcome was bladder pressure expressed in mmHg. This could not be translated into the 181 
force acting on the skin because neither the true conta t area nor the actual pressure 182 
applied to each pin was known. The bracelet was applied on one forearm and bladder 183 
pressure was increased incrementally and measured with a strain gauge pressure 184 
transducer; the threshold pressure was recorded by pressing the hold button on the 185 
voltmeter when the cat reacted to the stimulus (the voltage was directly proportional to 186 
the pressure). The authors found that, whilst the tr sholds varied a lot between 187 
different cats (68 to 202 mmHg in six cats), thresholds within each cat were consistent. 188 
This pressure algometer was used by the same authors to evaluate the analgesic efficacy 189 
of subcutaneous butorphanol (0.4 mg kg-1) and carprofen (4 mg kg-1). The NSAID was 190 
tested in a second phase of the trial, after kaolin was injected intradermally in the 191 
forearm to produce a model of inflammatory pain. In that study, the comparison 192 
between MTs measured before and after the administration of the opioid detected 193 
butorphanol antinociception. Excessively variable thresholds were obtained with the 194 
inflammatory model making this approach ineffective. The authors concluded that the 195 
device was light and easy to use and allowed the cats to remain unrestrained during 196 
testing. The repeatability of the thresholds was considered acceptable by the authors, 197 
who concluded that the algometer could be used for analgesic pharmacologic studies in 198 
cats (Dixon et al. 2007).  However, the same authors developed and tested the device, 199 
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which may have resulted in a certain degree of bias, although the device has been 200 
further modified and used by others who have confirmed its utility (Steagall et al. 2007; 201 
Millette et al. 2008; Slingsby et al. 2012).  202 
Mechanical thresholds have also been used in cats to tudy experimentally 203 
induced visceral nociception (Sawyer & Rech 1987; Sawyer et al. 1993). A subsequent 204 
study (Briggs et al. 1998) investigated the analgesic effect of oxymorphone, 205 
butorphanol and acepromazine, alone and in combination, using this model. A silastic 206 
balloon catheter, inserted into the rectum and connected via a rubber tube to a plastic 207 
jug was pressurised to selected incremental values for 30-second periods. A positive 208 
result was considered when an undefined behavioural response was evoked. The authors 209 
interspersed lower pressures to prevent conditioning to the increasing pressures used. 210 
Although the model has been successfully used in horses (Muir & Robertson 1985) and 211 
found robust and reliable in rodents (Jones et al. 2004; Arvidsson et al. 2006; Nissen et 212 
al. 2018), its validity for investigating colorectal noxious distension was questioned by a 213 
more recent study in horses (Sanchez et al. 2005). The physical properties of the balloon 214 
are relevant and materials with linear compliance, such as mylar, should be selected 215 
over latex in order to ensure proper pressure application to the colorectal wall (Sanchez 216 
et al. 2005). Another drawback of this model is that it may fail to differentiate 217 
behavioural responses caused by nociception from thse caused by an urge to defecate.  218 
More recent studies used precision pressure algometers, such as the Electronic 219 
von Frey Anaesthesiometer (EVF) and the Small Animal ALGOmeter (SMALGO). The 220 
former represents the electronic version of the vonFrey filaments and has been used 221 
most recently to assess acute and chronic pain in dogs and cats (Adami et al. 2018; 222 
Addison & Clements 2017). The EVF uses a sensory probe equipped with a rigid tip 223 
applying a force varying from 0 to 1000 g, which is measured, displayed and stored by 224 
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the control unit. The SMALGO has been specifically developed for laboratory rodents 225 
and shares the same working principle as the EVF. However, it has a finger-mounted 226 
sensor probe whose applicable force ranges from 0 to 1500 g. With both devices, a 227 
progressively increasing force is applied by the oprator over the targeted area, until an 228 
end-point behavioural response is observed. Althoug the stimulus is generally applied 229 
over an undefined time-period, most authors set a cut-off pressure/force value to avoid 230 
iatrogenic injury. 231 
Addison and Clements (2017) found that use of both the von Frey filaments and 232 
the EVF, applied to the metacarpal/metatarsal pad to assess paw withdrawal thresholds, 233 
resulted in differentiation between healthy cats and those with osteoarthritis (Addison 234 
and Clements 2017). Another recent study evaluated th  inter-rater and inter-device 235 
reliability of TTs measured with both the EVF and the SMALGO in non-painful cats 236 
(Adami et al. 2018). The authors found that the reliability of the measurements 237 
decreased after repetition within time-intervals shorter than one hour, indicating that the 238 
level of cooperation of feline patients may decrease after repeated testing or, 239 
alternatively, that the cats may anticipate the stimulus in order to end it. Similarly, 240 
learning and stimulus anticipation, resulting in decreased TTs have been described in 241 
dogs using algometry (Coleman et al. 2014). In another study, the SMALGO, applied to 242 
the skin of the upper lip, dorsal to the end of the canine root, was evaluated in cats with 243 
chronic gingivostomatitis, as compared to a healthy control group (Machin et al. 244 
2019b). Although the authors found a low inter-observer and intra-observer variability, 245 
the study failed to differentiate between healthy and diseased cats. Moreover, there was 246 
no correlation between the scores of the chronic gingivostomatitis scale, used by the 247 
authors to score the severity of the oral lesions, a d the thresholds measured in diseased 248 
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cats. Overall, these findings suggested that mechani al sensory testing with the 249 
SMALGO is not a reliable method to evaluate chronic oral pain in cats.  250 
A final study compared the use of the EVF and von Frey filaments at different 251 
anatomical sites of non-painful cats (Machin et al. 2019a). The authors found a 252 
moderate agreement between the two devices, as suggested by the intra-class correlation 253 
coefficient of 0.49 (CI=0.13-0.70); however, the willingness of the cats to cooperate 254 
decreased with the repetition of the measurements after 24 hours. This drawback may 255 
limit the applicability of mechanical NTT in the clinical setting, where repeated testing 256 
may be needed to adjust the analgesic therapy to meet th  patient’s requirement. Despite 257 
its limitations, it is worth considering that one potential advantage of the mechanical 258 
NTT over thermal, electrical and chemical techniques may be that the use of pressure 259 
thresholds is often perceived, by both clinicians ad cat owners, as less invasive and 260 
harmful than other types of stimuli. This aspect may allow and encourage the 261 
development of  protocols to increase the clinical application of TT testing, for routine 262 
assessment of pain in cats. 263 
At the date of writing, although inter-observer variability appears to be minimal 264 
for non-repeated TT measurements, there is still no evidence that, in cats, the thresholds 265 
consistently correlate with the severity of the clini al condition that causes pain, or with 266 
the intensity of pain itself. More prospective studies on the use of TTs in cats with 267 
clinical pain are needed to draw more solid conclusions with respect to the clinical 268 
usefulness of modern pressure algometers in this species. Even when used for testing 269 
analgesics in an experimental setting the documented thresholds have been highly 270 
variable making it difficult to record an antinociceptive effect. 271 
 272 
Thermal stimulation 273 
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A number of studies investigated the applicability of TT testing in various feline 274 
nociceptive models (Table 2). Thermal stimulation relies on the activation of two 275 
subtypes of nociceptors: mechano-heat units activated by noxious mechanical and hot 276 
thermal stimuli, and mechano-cold units activated by noxious mechanical and cold 277 
thermal stimuli (Djouhri & Lawson 2004). Two differnt outcome variables are often 278 
used during thermal stimulation: latency (the time elapsed between the start of 279 
application of a constant temperature and the observation of the target behavioural 280 
response) and threshold temperature (the measured temperature at which the response 281 
occurs with the application of an increasing temperature) (Casey & Morrow 1983; 282 
Slingsby & Taylor 2007; Addison & Clements 2017). Hot thermal testing is most 283 
commonly described, although cold (7°C temperature-controlled pressure-plate system) 284 
has also been used in cats and found more useful than kinetic gait analysis to 285 
differentiate between healthy limbs and those with osteoarthritis (Addison & Clements 286 
2017).  287 
There is a general concern that noxious thermal stimulation may activate mostly C 288 
but not Aδ fibres and therefore result in incomplete activation of nociceptive pathways, 289 
making the thermal model less likely than others to resemble the complexity of clinical 290 
pain (Mao 2012). Selectivity of receptor activation s greatly dependent on the mode of 291 
delivery of the thermal stimulus and on the steepness of the heating slope. In a murine 292 
model, stimuli capable of heating the cutaneous surface as rapidly as 6.5°C second-1, 293 
such as laser radiation, activated Aδ units with a response latency of 2 seconds after the 294 
onset of the stimulus (Yeomans & Proudfit 1996). In contrast, thermal conduction, by 295 
means of rates of skin heating as slow as 0.9 °C second-1, with relatively long latency of 296 
5-6 seconds, evoked action potentials selectively in C nociceptors (Yeomans & Proudfit 297 
1996). In cats, as well as in primates, thermal stimuli above 45 ºC are capable of 298 
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activating both the Aδ and C fibres, which respond with increasing discharge as the 299 
temperature is increased (Beck et al. 1974; Casey & Morrow 1983). Both laser and 300 
radiant heat stimulation responses are measured as latencies, whereas temperature 301 
thresholds are measured with contact thermodes. Contact thermodes unavoidably apply 302 
a pressure on the skin surface, which may also activate low-threshold non-nociceptive 303 
Aß fibres (Nathan et al. 1986; Svensson et al. 1997) but this is less likely to cause 304 
confusion if the thermode is continuously in contact with the skin vs an intermittent 305 
application.  306 
Despite these limitations, thermal nociception has been used extensively over the 307 
last two decades and its use in cats has been more repeatable and reliable than both 308 
mechanical and electrical models. The use of cats to investigate and quantify afferent 309 
activity in response to thermal stimulation dates back to the 1960s (Kenshalo et al. 310 
1967; Beck et al. 1974). One study used rapid onset thermal pulses ranging from 43 to 311 
60ºC and concluded that the probability of evoking a nocifensive response in cats 312 
increased for cutaneous thermal stimuli between 50 and 55ºC (Casey & Morrow 1983).  313 
In 2002, Dixon and colleagues developed a TT device, subsequently produced by 314 
Top Cat Metrology Ltd, which has been used for evaluation of various analgesics in cats 315 
(Dixon et al. 2002). A probe equipped with a heater el ment and a temperature sensor 316 
was held against a clipped area of the thorax using a  elastic band and a pressure 317 
bladder, inflated to 100 mmHg to ensure even contact between the skin and the probe. 318 
The probe was heated at 0.6ºC second-1 until either a pre-defined behavioural response 319 
was elicited, or a cut-off value of 60ºC was reached. The measurement of the TTs with 320 
this device was repeatable and well tolerated by the cats but resulted in minor skin 321 
lesions. A further crossover trial carried out by the same authors in non-painful cats 322 
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found the device useful to differentiate between pethidine antinociception and a placebo 323 
treatment (Dixon et al. 2002).  324 
This device was used in various subsequent studies with a standardised approach, 325 
characterised by a cut-off temperature decreased to 55-55.5°C, to prevent skin lesions, 326 
the same application mode of the thermal stimulus and similar areas of the body tested. 327 
Many of these reports investigated the usefulness of TTs alone to evaluate the 328 
pharmacodynamics of various analgesics (Lascelles & Robertson 2004b; Robertson et 329 
al. 2005; Johnson et al. 2007; Wegner & Robertson 2007; Slingsby & Taylor 2008; 330 
Robertson et al. 2009; Slingsby et al. 2009; Slingsby et al. 2010) (Table 2), whereas 331 
some others compared mechanical and TT testing for the same purpose (Steagall et al. 332 
2006; Steagall et al. 2007; Millette et al. 2008; Slingsby et al. 2012; Ambros and Duke 333 
2013; Addison & Clements 2017) (Table 3).  334 
In the context of pharmacological studies, TT testing has been commonly used to 335 
describe the analgesic effects of various opioids in cats, including “opioid-like” agents 336 
such as tramadol and tapentadol (Lascelles & Robertson 2004a; Johnson et al. 2007; 337 
Wenger & Robertson 2007; Pypendop et al. 2009; Steagall et al. 2015; Doodnaught et 338 
al. 2017). Overall, the results of these studies suggest that the thermal nociceptive 339 
model consistently detects opioid-antinociception, despite some contradictory findings; 340 
whilst buccal buprenorphine was found by some authors t  significantly increase TTs 341 
(Robertson et al. 2005a; Doodnaught et al. 2018), it resulted in inconsistent thermal 342 
antinociception in another study (Steagall et al. 2015). A possible reason for these 343 
conflicting results is the variable bioavailability of buprenorphine after oral 344 
transmucosal administration, which was found to range between 16 and 60% (Pypendop 345 
et al. 2014). 346 
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An important drawback of using TTs to detect opioid antinociception in cats is 347 
that opioids increase body temperature (Niedfeldt & Robertson 2006; Posner et al. 348 
2010), an effect that may act as a confounding variable and potentially affect the 349 
outcome because the raised baseline temperature may not be comparable to an untreated 350 
control.  351 
The thermal nociceptive model has also been used to investigate the analgesic 352 
pharmacodynamics of α2-adrenoceptor agonists in cats, with conflicting results. 353 
Slingsby & Taylor (2008) found that, among five different intramuscular 354 
dexmedetomidine doses tested, only the highest one (40 μg kg-1) caused an increase in 355 
thresholds, which was less significant than with buprenorphine, used as positive control 356 
treatment. Another study failed to detect any difference using TT between intramuscular 357 
and oral transmucosal dexmedetomidine at the same dose (Slingsby et al. 2009). 358 
In a subsequent report the same authors detected an a ditive antinociceptive effect 359 
with buprenorphine and dexmedetomidine combined in no -painful cats (Slingsby et al. 360 
2010). In the light of these inconsistent findings, the authors concluded that the α2-361 
adrenoceptor agonists-induced vasoconstriction may alter the response to thermal 362 
stimulation by decreasing blood flow in the skin, which makes the thermal model 363 
suboptimal when this class of analgesics is investigated (Slingsby et al. 2009). The 364 
decrease in skin temperature appears to be dose dependent with doses >5 µg/kg causing 365 
some decrease (Pypendop personal communication 2020).   366 
Besides the contact thermal algometer developed by Dixon (Dixon et al. 2002), 367 
another device using remote carbon dioxide laser stimulation has been validated for cats 368 
more recently (Farnworth et al. 2013a, Farnworth et al. 2013b). A visible, non-thermal, 369 
helium laser was used to guide and aim the thermal carbon dioxide laser beam over a 370 
target area of the cats’ shaved thorax. The wavelength of the thermal laser was 10.6 μm, 371 
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with a maximum power output of 10 W. The exhibition f either a body shift (e.g. 372 
rising) or the panniculus reflex were considered a positive response. The laser device 373 
was evaluated with respect to intra-individual and i ter-individual variability. The 374 
authors found that, although individual responses were repeatable over a three-day 375 
period, the repeatability decreased after the third day of testing (Farnworth et al. 2013a). 376 
Moreover, heavier cats had increased latencies, sugge ting that fat deposition in the sub-377 
cutaneous layers, where the skin nociceptors occur, may act as a buffer and attenuate the 378 
response (Farnworth et al. 2013b). This laser device was used to investigate the 379 
analgesic effects of opioids, NSAIDs and α2-adrenoceptor agonists (Farnworth et al. 380 
2015). Although the results of this one study were inconclusive and did not allow 381 
differentiation between treatment groups, it is worth considering that using a CO2 laser 382 
thermal stimulator may offer some advantages over other types of thermal probes. The 383 
monochromatic, long wavelength results in complete absorption regardless of the 384 
degree of pigmentation of the skin, which may be an issue with radiant heat methods 385 
(Le Bars et al. 2001). Moreover, the heating slope is steeper than with contact 386 
thermodes as the target temperature is reached within milliseconds, and the lack of 387 
cutaneous contact ensures avoidance of inadvertent activation of non-nociceptive nerve 388 
fibres (Treede et al. 1984; Le Bars et al. 2001). However, one potential disadvantage is 389 
the lack of skin temperature measurement before applic tion of the stimulus, as well as 390 
the risk for blistering that was observed in some study cats.  391 
Overall, many studies suggest that thermal nociception is well tolerated in cats 392 
and the results are reproducible (Lascelles & Robertson 2004a; Robertson et al. 2005a; 393 
Robertson et al. 2005b; Steagall et al. 2006; Pypendop et al. 2009). A limitation of TTs 394 
may be their applicability to pharmacodynamic studies focusing on analgesics that have 395 
the potential to alter the skin temperature in cats, such as opioids (Niedfeldt & 396 
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Robertson 2006; Posner et al. 2007) and α2-adrenoceptor agonists at high doses - an 397 
effect that may affect the thresholds or the comparison with control animals and act as a 398 
confounding variable. The thermode method is unlikely to be very useful for 399 
investigating pain in clinical patients because it is ime consuming, requires a skin area 400 
to be shaved for its placement and the repeated applic tion of noxious heat may be 401 
regarded as upsetting by some animal caregivers. Methods that are more ‘portable’, 402 
such as a laser, that can be focused on an area of interest and used intermittently, may 403 
be more useful in the clinical setting but may still be unacceptable due to the repeated 404 
testing (Farnworth et al. 2015). 405 
 406 
Electrical stimulation 407 
The potential advantage of electrical stimulation is that it is reproducible, measurable 408 
and quantifiable. Single electrical stimuli of short duration, usually between 10 and 20 409 
ms, are often applied in a sudden, abrupt fashion to measure latencies. Alternatively, 410 
electrical stimulation of gradually increasing intesity in the form of trains of stimuli, 411 
usually lasting some hundreds of ms, have been usedin rodents to evaluate different 412 
responses organised on a hierarchical basis, namely reflex movements of the tail 413 
followed by more complex behavioural responses, such as attempts to escape  (Le Bars 414 
et al. 2001).  415 
A number of studies from the 1970s described the use of electrical stimulation in 416 
cats (Anderson & Pearl 1974; Berkley & Parmer 1974; Anderson & Pearl 1975; Lisney 417 
1978). However, the majority of these neurophysiological studies were conducted in 418 
cats under general anaesthesia and did not use behavioural evaluation, which is an 419 
intrinsic component of NTT.   420 
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More recently, Millette and colleagues evaluated the use of electrical threshold 421 
testing to characterise the antinociceptive effects of meperidine in pain-free cats 422 
(Millette et al. 2008). The authors used a current generator to deliver repeated stimuli 423 
with a duration of 1 ms and 1 ms delay between pulses, through two electrodes held 424 
against a clipped area of the mid-thorax. The current was increased at 1mA second -1, 425 
and the cut-off was set at 5 mA. The main finding of Millette’s study was that the 426 
electrical stimulus failed to detect meperidine antinociception, whereas the thermal and 427 
the TTs, also used by the authors, were both found useful for this purpose.  428 
The application of electrical stimulation for nociceptive testing in cats has failed 429 
to earn popularity. A reason for this may be the many limitations of the electrical 430 
stimulus, which differs from every natural type of stimulus that an animal may 431 
encounter in its physiological environment.  432 
Although studies conducted in both human volunteers and dogs demonstrated that 433 
electrical stimuli with frequencies of 2000, 250 and 5 Hz can selectively stimulate the 434 
Aß, the Aδ and the C fibres, respectively (Finkel et al. 2002; Sakai et al. 2004; Watabiki 435 
et al. 2010), to the best of these authors’ knowledge, there are no published experiments 436 
in cats to verify these findings. As a result, nonselectivity of activation is another 437 
potential drawback of electrical stimulation, which an result in activation of Aδ, C as 438 
well as larger diameter fibres not directly implicated in nociception (Le Bars et al. 439 
2001). Finally, there are technical considerations that may limit the applicability of 440 
electrical nociception. Based on its thickness and hy ration, the skin offers variable 441 
impedance to electrical stimulation, which can considerably affect the response. This 442 
variability can be minimised by using a constant current and measuring impedance prior 443 
to stimulation (Le Bars et al. 2001). 444 
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The very limited evidence, together with the small number of reports in this 445 
species, does not allow any conclusive statement with respect to the usefulness of the 446 
electrical nociceptive model in cats.  447 
 448 
Chemical stimulation 449 
Chemical stimuli differ from any other type of nociceptive stimulation, as they are slow, 450 
progressive and of longer duration. As a result, the c emical nociceptive model mostly 451 
produces complex behavioural responses rather than simple reflexes (Le Bars et al. 452 
2001). Algogenic or irritant agents, such as capsaicin, formalin and kaolin, are either 453 
applied on the intact skin or injected subcutaneously or intradermally, to produce 454 
hyperalgesia and inflammation, and therefore evoke pain. A local cutaneous injury may 455 
produce primary hyperalgesia within the injured area, as well as secondary, neurogenic 456 
hyperalgesia, caused by central sensitisation, in the normal surrounding skin. (Baumann 457 
et al. 1991).  458 
The duration of inflammation – and therefore of hyperalgesia – varies between 459 
chemical agents, routes of administration and, possibly, animal models. In rodents, both 460 
formalin and capsaicin reproduce an inflammatory model characterised by two well-461 
identified phases, of which the acute one occurs within minutes from intradermal 462 
injection and lasts a few minutes, followed by secondary hyperalgesia starting around 463 
10 minutes (Wheeler-Aceto & Cowan 1991; La et al. 2017). In cats, subcutaneous 464 
injection of kaolin in the paw results in well-defined and reproducible inflammation that 465 
lasted up to five days (Giraudel et al. 2005; Giraudel et al. 2009). 466 
The failure to quantify NSAID associated analgesia and successfully differentiate 467 
between different agents within the same pharmaceutical class seems to be a common 468 
denominator of the studies that used the mechanical and thermal nociceptive models. 469 
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Conceptually, since these models do not have an inflammatory component to the 470 
nociceptive stimulus it is not surprising that they have not succeeded. The addition of an 471 
inflammatory chemical has been used to test the anti-inflammatory antinociceptive 472 
effect of these drugs. 473 
A study from the late 1970s used formalin, injected subcutaneously into the 474 
forepaw, to induce inflammation and then quantify the analgesic effects of morphine 475 
and meperidine with thermal latency testing in cats (Dubuisson & Dennis 1977). 476 
Similarly, kaolin was used in various studies to investigate NSAID associated 477 
antinociception in cats (Giraudel et al. 2005; Dixon et al. 2007; Taylor et al. 2007; 478 
Giraudel et al. 2009). Taylor and colleagues combined kaolin injection and TT testing to 479 
investigate the analgesic efficacy of ketoprofen in seven cats, and found that the 480 
combination of the two techniques did not detect antinociception. Ketoprofen increased 481 
the TT outside the 95% confidence interval but the study was probably underpowered 482 
(Taylor et al. 2007).  483 
The intradermal or subcutaneous injection of chemicals has been used only in 484 
experimental cats with the greatest utility for testing the analgesic effect of drugs that 485 
have an anti-inflammatory component. There are no potential applications in the clinical 486 
setting.  487 
 488 
Mixed nociceptive models comparing thermal and mechanical thresholds    489 
A number of studies conducted in cats reported the simultaneous use of several 490 
threshold testing methods to investigate the pharmacodynamics of various analgesic 491 
agents, most of which were opioids (Steagall et al. 2006; Steagall et al. 2007; Millette et 492 
al. 2008; Steagall et al. 2008; Slingsby et al. 2012; Table 3).  493 
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The studies using different types of nociceptive stimulation seem to further 494 
confirm that the TTs, and to some extent the mechani al ones, consistently detect the 495 
antinociceptive effect of opioids (Millette et al. 2008; Slingsby et al. 2012), whilst less 496 
convincing findings were obtained when the two models were used to investigate 497 
ketamine (Ambros & Duke 2013). The authors concluded that, because ketamine seems 498 
to be more effective in pathological pain states characterised by central facilitation 499 
(Ghorpade and Advokat 1994), a model of acute nociception may not be the most 500 
appropriate one to detect ketamine analgesia (Ambros & Duke 2013).   501 
Tramadol was found to have a limited effect on both TT and TTs (Steagall et al. 502 
2008), although the increase in thresholds was more pronounced when tramadol was 503 
combined with 0.1 mg kg-1 acepromazine. However, the sedative effect, detected in all 504 
cats that received acepromazine (Steagall et al. 2008), could represent a confounding 505 
variable, by decreasing the behavioural responsiveness of the cats to nociceptive 506 
stimulation. 507 
 508 
Conclusions  509 
Mechanical and TT testing are the NTT methods that were found more reliable for use 510 
in cats within the last two decades, with TTs being the most widely applied in 511 
pharmacological studies. As indicated above TT testing may be influenced by changes 512 
in skin temperature associated with particular drugs. With a thermode technique the 513 
baseline temperature is measured but this needs to be accounted for with other methods 514 
where the skin temperature is not recorded automatically.  515 
Whilst TT testing is mostly applicable to the experimental setting, there is a 516 
promising, increasing tendency to test the usefulness of MTs in cats with clinical pain. 517 
Therefore, mechanical nociception may, in the future, become part of the routine 518 
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evaluation of feline patients suffering from various pain syndromes. The low 519 
repeatability of mechanical NTT within short time-intervals, as well as the lack of data 520 
in patients with acute and chronic pain, represent major limitations to its clinical 521 
application. Some studies showed that both MT and TT testing did not detect NSAID 522 
associated analgesia, suggesting that, in order to investigate the efficacy of drugs whose 523 
analgesic effect is mostly based on their anti-inflammatory properties, inflammation 524 
must be produced first.   525 
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Table 1. Studies investigating the use of mechanical thresholds in both experimental and 
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Table legend: NA: not applicable; IV: intravenous; ACP: Acepromazine; MT: mechanical 
thresholds; OVH: Ovariohysterectomy; FSR: Force-Sensing Resistor; IM: intramuscular; SC: 
subcutaneous; NSAIDs: Non-Steroidal Anti-inflammatory Drugs; EVF: Electronic von Frey 
Anaesthesiometer; OTM: oral transmucosal; VFF: von Frey filaments; SMALGO: Small 
Animal Algometer; CGS: Chronic Gingivo Stomatitis.  
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either IV or 















































et al. 2017 







































et al. 2018 
(Letter to the 
Editor) 





































at two rates 
of infusion 
















































































































































Table legend: NA: not applicable; GV1: Governing Vess l 1; IV: intravenous; IM: 
intramuscular; SC: subcutaneous; TT: thermal threshold ; SL: sublingual; TC: transcutaneous 
(compounded in pluronic lecithin organogel PLO); OTM: oral transmucosal; PO: oral 




















































Steagall et al. 
2006 




10 mm long, 
10 mm wide 






































Morphine was the 
most effective 
treatment in 
increasing both TT 
and MT, as compared 
to both control group 
and baseline 
thresholds 





































10 mm long, 
10 mm wide 









































the thermal model 
was superior to the 
mechanical one), but 
failed to detect 
carprofen analgesia  











































10 mm long, 
10 mm wide 




































SC tramadol had 
limited effect on both 
TT and MT, whereas 
the combination ACP 
+ tramadol increased 
both TT and MT 













 Leg shake, 
head turn, 
























10 mm long, 
10 mm wide 




































failed to detect 
meperidine analgesia, 
whereas both TT and 
MT were found 
useful for this 
purpose.  
















































stimuli via two 
skin electrodes 
off) area of 
the mid-
thorax 
look at, lick or 
bite the 
electrodes 









stimuli at a 
rate of 1 mA 
sec-1 
(duration of 













10 mm long, 
10 mm wide 

































increased both MT 
and TT values 
(compared to both 
saline and baseline 
values)  











by Dixon et 






 As described 



















10 mm long, 
10 mm wide 


























by Dixon et 
al. 2002 
MT were not affected 
by buprenorphine 
treatment, whereas 
TT increased after 
buprenorphine 
administration 




of buprenorphine  





with a 2.4 mm 
As 
described 




 As described 






by Dixon et 
al. 2007 
 
 diameter ball –
bearing pin 











10 mm long, 
10 mm wide 







































Only the low dose of 
ketamine minimally 
affected both TT and 
MT. The results were 
inconclusive and 
ketamine analgesia 



































































and cats with 
OA) 
Walking off 




each paw was 








MT, measured with 
both EVF and VFF, 
were lower in cats 
with OA than in the 
healthy ones. 
Regarding TT, only 
the cold ones allowed 
differentiation 
between healthy and 
diseased limbs  



































Table legend: SC: subcutaneous; IM: intramuscular; TT: thermal thresholds; MT: mechanical thresholds; ACP: Acepromazine; OA: 3 
Osteoarthritis; EVF: Electronic von Frey Anaesthesiometer; VFF: Von Frey Filaments  4 
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